CYP3A4 and diabetes mellitus: Female sex, history of diabetes, and use of a CYP3A4 or Pgp inhibitor (moderate or strong) were also associated with higher anti-Xa activity (p < 0.001,p = 0.011, andp = 0.002, respectively).